Lifecore Biomedical, Inc. De (LFCR) Interest Expenses (2010 - 2025)

Lifecore Biomedical's Interest Expenses history runs 16 years deep, the most recent figure standing at $4.8 million for Q1 2025.

• In Q1 2025, Interest Expenses rose 43.71% year-over-year to $4.8 million; the TTM figure through May 2025 stood at $13.9 million (down 36.61% YoY), while the FY2024 annual figure was $14.7 million, up 4065.34% from the prior year.
• Interest Expenses was $4.8 million for Q1 2025 at Lifecore Biomedical, up from $4.6 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $12.1 million in Q2 2024 to a low of -$12.6 million in Q2 2022.
• Historically, Interest Expenses has averaged $3.1 million across 5 years, with a median of $3.5 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Interest Expenses plunged 641.01% in 2022, then soared 3342.05% in 2024.
• A 5-year view of Interest Expenses shows it stood at $2.8 million in 2021, then soared by 30.39% to $3.6 million in 2022, then decreased by 10.17% to $3.2 million in 2023, then surged by 42.64% to $4.6 million in 2024, then rose by 4.69% to $4.8 million in 2025.
• The last three Interest Expenses figures came in at $4.8 million (Q1 2025), $4.6 million (Q4 2024), and $4.4 million (Q3 2024), per Business Quant data.